TrialMenopause (New York, N.Y.)2019

Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.

Lon S Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.